Answers are grounded in this paper and cite their sources.
Observational analysis reveals GTX-11 reduces fibrosis and inflammation in preclinical models, suggesting its therapeutic promise.
Altogether, our studies reveal that GTX-11 is an effective antifibrotic both in vivo and in vitro, suggesting that GTX-11 has potential as a therapeutic option for fibrotic ILDs.
No takes yet. Share an insight, caveat, or question.
Montes-Worboys et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: